| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.974 | 0 | 4.812 | 5.641 | 5.230 | 4.109 | 6.783 | 9.604 | 9.602 | 13.412 |
| Total Income - EUR | 3.974 | 0 | 4.812 | 5.641 | 5.230 | 4.109 | 6.783 | 9.604 | 9.602 | 13.412 |
| Total Expenses - EUR | 3.780 | 0 | 5.438 | 5.239 | 5.602 | 3.552 | 3.888 | 2.082 | 4.221 | 3.245 |
| Gross Profit/Loss - EUR | 194 | 0 | -627 | 401 | -372 | 557 | 2.895 | 7.522 | 5.381 | 10.167 |
| Net Profit/Loss - EUR | 75 | 0 | -675 | 345 | -529 | 444 | 2.692 | 7.240 | 4.563 | 8.572 |
| Employees | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Calmodent Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 831 | 0 | 454 | 817 | 477 | 581 | 3.281 | 8.432 | 7.630 | 9.902 |
| Inventories | 0 | 0 | 11 | 118 | 250 | 132 | 129 | 143 | 143 | 142 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34 | 93 |
| Cash | 831 | 0 | 443 | 698 | 226 | 449 | 3.152 | 8.289 | 7.454 | 9.667 |
| Shareholders Funds | 353 | 0 | 147 | 489 | -50 | 395 | 3.078 | 8.199 | 5.518 | 8.613 |
| Social Capital | 45 | 0 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 477 | 0 | 307 | 328 | 526 | 185 | 203 | 233 | 2.112 | 1.289 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Calmodent Srl